Candace Wooten-Reed
Medical · Atlanta, GANPI 1750529764
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 539 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 57 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,304 and has fallen 67.2% since, to $1,084 in 2025. Among medical clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 539 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$975
- Biohaven Pharmaceuticals, Inc.$819
- GSK$570
- Lilly USA, LLC$550
- Amgen$516
- plus $5K from 51 others
What the payments were for
- Consulting fees$8008%
- Food & beverage$9,22892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$800
- TRELEGY ELLIPTA$120
- NEXLIZET$118
- NEXLETOL$118
- VRAYLAR$101
How this compares
$10,028 in reported general payments places this provider in the 90th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 83 | $76,616 |
| JanuviaSitagliptin Phosphate | 38 | $56,273 |
| OzempicSemaglutide | 41 | $55,668 |
| FarxigaDapagliflozin Propanediol | 49 | $55,275 |
| XareltoRivaroxaban | 40 | $54,919 |
| TrulicityDulaglutide | 23 | $42,206 |
| JardianceEmpagliflozin | 36 | $40,016 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $33,141 |
| LinzessLinaclotide | 22 | $27,647 |
| MounjaroTirzepatide | 14 | $18,612 |
| TradjentaLinagliptin | 11 | $13,647 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,343 |
| Metoprolol Succinate | 189 | $3,145 |
| Nifedipine ErNifedipine | 94 | $3,101 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 95 | $3,080 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $42 | $76,61683 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $550 | $60,81937 claims |
| AstraZenecaFarxiga, Symbicort | $489 | $58,61862 claims |
| MerckJanuvia | $167 | $56,27338 claims |
| Novo NordiskOzempic | $975 | $55,66841 claims |
| Johnson & JohnsonXarelto | $16 | $54,91940 claims |
| Boehringer IngelheimJardiance, Tradjenta | $207 | $53,66247 claims |
| GSKTrelegy Ellipta | $570 | $33,14132 claims |
| AbbVieLinzess | $1,714 | $27,64722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 950 medical providers in Georgia.
Other medical in Atlanta
- Kimberly OrleckAtlanta$727K
- Danna Dennis-CalderAtlanta$87K
- Ferrina ShethAtlanta$49K
- Adriana RuizAtlanta$39K
- Punam PunjaAtlanta$31K
- Adrienne AndersonAtlanta$25K
- Jeremiah RobinsonAtlanta$23K
- Steven SchmittAtlanta$15K
- Taylor WeintraubAtlanta$15K
- Margaret SellersAtlanta$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.